Antigen presentation in graft-vs-host disease - PubMed (original) (raw)
Review
. 2003 Dec;31(12):1187-97.
doi: 10.1016/j.exphem.2003.09.017.
Affiliations
- PMID: 14662324
- DOI: 10.1016/j.exphem.2003.09.017
Free article
Review
Antigen presentation in graft-vs-host disease
Warren D Shlomchik. Exp Hematol. 2003 Dec.
Free article
No abstract available
Similar articles
- [Antigen presentation and graft-versus-host disease].
Koyama M. Koyama M. Rinsho Ketsueki. 2013 Oct;54(10):1951-7. Rinsho Ketsueki. 2013. PMID: 24064848 Review. Japanese. No abstract available. - [Hematopoietic stem cell transplantation].
Morishima Y. Morishima Y. Nihon Rinsho. 2005 Apr;63 Suppl 4:690-4. Nihon Rinsho. 2005. PMID: 15861730 Review. Japanese. No abstract available. - Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
Boeck S, Hamann M, Pihusch V, Heller T, Diem H, Rolf B, Pihusch R, Kolb HJ, Pihusch M. Boeck S, et al. Bone Marrow Transplant. 2006 Jan;37(1):57-64. doi: 10.1038/sj.bmt.1705217. Bone Marrow Transplant. 2006. PMID: 16258529 - Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
Kawasaki Y, Sato K, Hayakawa H, Takayama N, Nakano H, Ito R, Mashima K, Oh I, Minakata D, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Fujiwara SI, Ohmine K, Muroi K, Kanda Y. Kawasaki Y, et al. Biol Blood Marrow Transplant. 2018 Aug;24(8):1563-1574. doi: 10.1016/j.bbmt.2018.04.016. Epub 2018 Apr 17. Biol Blood Marrow Transplant. 2018. PMID: 29678638 - [Graft vs. host disease and graft vs. leukemia/tumor effect].
Okamoto S. Okamoto S. Nihon Rinsho. 2003 Sep;61(9):1484-7. Nihon Rinsho. 2003. PMID: 14515713 Review. Japanese. No abstract available.
Cited by
- Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation.
Hauri-Hohl MM, Keller MP, Gill J, Hafen K, Pachlatko E, Boulay T, Peter A, Holländer GA, Krenger W. Hauri-Hohl MM, et al. Blood. 2007 May 1;109(9):4080-8. doi: 10.1182/blood-2006-07-034157. Epub 2007 Jan 9. Blood. 2007. PMID: 17213290 Free PMC article. - 60 Years Young: The Evolving Role of Allogeneic Hematopoietic Stem Cell Transplantation in Cancer Immunotherapy.
Cieri N, Maurer K, Wu CJ. Cieri N, et al. Cancer Res. 2021 Sep 1;81(17):4373-4384. doi: 10.1158/0008-5472.CAN-21-0301. Epub 2021 Jun 9. Cancer Res. 2021. PMID: 34108142 Free PMC article. Review. - Advances in the ocular complications after hematopoietic stem cell transplantation.
Lv X, Li H, Su S, Fan S. Lv X, et al. Ann Hematol. 2024 Oct;103(10):3867-3880. doi: 10.1007/s00277-024-05678-z. Epub 2024 Feb 26. Ann Hematol. 2024. PMID: 38403713 Review. - Organ-derived dendritic cells have differential effects on alloreactive T cells.
Kim TD, Terwey TH, Zakrzewski JL, Suh D, Kochman AA, Chen ME, King CG, Borsotti C, Grubin J, Smith OM, Heller G, Liu C, Murphy GF, Alpdogan O, van den Brink MR. Kim TD, et al. Blood. 2008 Mar 1;111(5):2929-40. doi: 10.1182/blood-2007-06-096602. Epub 2008 Jan 4. Blood. 2008. PMID: 18178870 Free PMC article. - TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
El-Asady R, Yuan R, Liu K, Wang D, Gress RE, Lucas PJ, Drachenberg CB, Hadley GA. El-Asady R, et al. J Exp Med. 2005 May 16;201(10):1647-57. doi: 10.1084/jem.20041044. J Exp Med. 2005. PMID: 15897278 Free PMC article.